Bp Plc maintained its stake in Laboratory Corporation of America Holdings (NYSE:LH) during the second quarter, according to its most recent disclosure with the SEC. The firm owned 12,400 shares of the medical research company’s stock at the end of the second quarter. Bp Plc’s holdings in Laboratory Corporation of America Holdings were worth $1,911,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Parallel Advisors LLC boosted its stake in Laboratory Corporation of America Holdings by 377.7% in the first quarter. Parallel Advisors LLC now owns 1,261 shares of the medical research company’s stock worth $177,000 after buying an additional 997 shares during the period. IFP Advisors Inc boosted its stake in Laboratory Corporation of America Holdings by 83.9% in the second quarter. IFP Advisors Inc now owns 1,146 shares of the medical research company’s stock worth $177,000 after buying an additional 523 shares during the period. Ingalls & Snyder LLC acquired a new stake in Laboratory Corporation of America Holdings during the first quarter worth approximately $206,000. Oppenheimer Asset Management Inc. acquired a new stake in Laboratory Corporation of America Holdings during the first quarter worth approximately $208,000. Finally, TNB Financial acquired a new stake in Laboratory Corporation of America Holdings during the second quarter worth approximately $208,000. Institutional investors and hedge funds own 91.89% of the company’s stock.

Laboratory Corporation of America Holdings (NYSE:LH) opened at 156.21 on Friday. The firm has a market cap of $15.90 billion, a price-to-earnings ratio of 21.88 and a beta of 0.94. Laboratory Corporation of America Holdings has a 1-year low of $119.51 and a 1-year high of $164.22. The firm’s 50-day moving average price is $155.35 and its 200-day moving average price is $144.27.

Laboratory Corporation of America Holdings (NYSE:LH) last released its quarterly earnings data on Wednesday, July 26th. The medical research company reported $2.47 earnings per share for the quarter, beating the consensus estimate of $2.40 by $0.07. Laboratory Corporation of America Holdings had a return on equity of 16.85% and a net margin of 7.57%. The firm had revenue of $2.50 billion during the quarter, compared to the consensus estimate of $2.47 billion. During the same period last year, the business posted $2.36 EPS. Laboratory Corporation of America Holdings’s quarterly revenue was up 4.9% on a year-over-year basis. On average, equities research analysts anticipate that Laboratory Corporation of America Holdings will post $9.51 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Bp Plc Continues to Hold Position in Laboratory Corporation of America Holdings (LH)” was published by Daily Political and is the sole property of of Daily Political. If you are viewing this story on another publication, it was illegally stolen and reposted in violation of United States & international copyright & trademark laws. The legal version of this story can be accessed at https://www.dailypolitical.com/2017/08/12/bp-plc-continues-to-hold-position-in-laboratory-corporation-of-america-holdings-lh.html.

LH has been the subject of a number of recent analyst reports. Craig Hallum restated a “buy” rating and issued a $179.00 price objective (up from $157.00) on shares of Laboratory Corporation of America Holdings in a research report on Thursday, July 27th. Credit Suisse Group reaffirmed a “buy” rating and issued a $146.00 price target on shares of Laboratory Corporation of America Holdings in a research note on Sunday, May 28th. BidaskClub raised Laboratory Corporation of America Holdings from a “hold” rating to a “buy” rating in a research note on Saturday, June 17th. ValuEngine lowered Laboratory Corporation of America Holdings from a “buy” rating to a “hold” rating in a research note on Saturday, June 3rd. Finally, Jefferies Group LLC lowered their price target on Laboratory Corporation of America Holdings from $159.00 to $157.00 and set a “hold” rating on the stock in a research note on Friday, April 28th. Seven research analysts have rated the stock with a hold rating, seven have issued a buy rating and one has assigned a strong buy rating to the company. Laboratory Corporation of America Holdings has an average rating of “Buy” and a consensus target price of $159.00.

In other Laboratory Corporation of America Holdings news, SVP Lance Berberian sold 3,613 shares of the firm’s stock in a transaction on Monday, May 22nd. The stock was sold at an average price of $139.84, for a total transaction of $505,241.92. Following the completion of the transaction, the senior vice president now owns 5,789 shares of the company’s stock, valued at $809,533.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Glenn A. Eisenberg sold 5,968 shares of the firm’s stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $159.46, for a total value of $951,657.28. Following the transaction, the chief financial officer now directly owns 18,122 shares of the company’s stock, valued at approximately $2,889,734.12. The disclosure for this sale can be found here. Insiders sold a total of 14,581 shares of company stock valued at $2,256,899 over the last ninety days. 0.90% of the stock is currently owned by company insiders.

About Laboratory Corporation of America Holdings

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD).

Want to see what other hedge funds are holding LH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Laboratory Corporation of America Holdings (NYSE:LH).

Institutional Ownership by Quarter for Laboratory Corporation of America Holdings (NYSE:LH)

Receive News & Ratings for Laboratory Corporation of America Holdings Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Laboratory Corporation of America Holdings and related companies with MarketBeat.com's FREE daily email newsletter.